Weikang Pharmaceutical released its report for the first quarter of 2024, achieving revenue of 200 million yuan, an increase of 2.15% year on year; net profit attributable to shareholders of listed companies was 243.35 million yuan, a year-on-year decrease of 11.59%.
维康药业：一季度净利润2433.5万元 同比下降11.6%
Weikang Pharmaceutical: Net profit of 243.35 million yuan in the first quarter decreased 11.6% year on year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.